1. Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus 
C. Eckmann, D. Nathwani, W. Lawson, S. Corman, C. Solem, J. Stephens, C. Macahilig, J. Li, C. Charbonneau, N. Baillon-Plot, S. Haider 
Clinical Microbiology and Infection 
Volume 21, Pages S33-S39 (September 2015)
DOI: /j.cmi
Copyright © Terms and Conditions

2. Fig. 1
Cohort selection for patient subgroup with methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft-tissue infections and peripheral vascular disease (PVD) and/or diabetes.
Clinical Microbiology and Infection  , S33-S39DOI: ( /j.cmi )
Copyright © Terms and Conditions

3. Fig. 2
Hospital length of stay in patients with methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections and peripheral vascular disease and/or diabetes receiving vancomycin or linezolid (propensity-score weighted). HDU, high-dependency unit; ICU, intensive care unit.
Clinical Microbiology and Infection  , S33-S39DOI: ( /j.cmi )
Copyright © Terms and Conditions

4. Fig. 3
Total and intravenous length of treatment in patients with methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections and peripheral vascular disease and/or diabetes receiving vancomycin or linezolid (propensity-score weighted).
Clinical Microbiology and Infection  , S33-S39DOI: ( /j.cmi )
Copyright © Terms and Conditions

5. Fig. 4
Hospital length of stay in patients with methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections and peripheral vascular disease receiving vancomycin or linezolid (propensity-score weighted). HDU, high dependency unit; ICU, intensive care unit.
Clinical Microbiology and Infection  , S33-S39DOI: ( /j.cmi )
Copyright © Terms and Conditions